Catalyst Wire Dossier Catalyst Wire Dossier

Encorafenib

encorafenib · Pierre Fabre Medicament
Drug timelines are a Plus or Pro feature.

31 regulatory and trial events tracked for Encorafenib, covering 2020-07-14 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Surgical or Radiotherapeutic Intervention Concerning Large Singular Stable to Progressive Metastases in Patients With BRAFV600-mutated Melanoma Receiving Treatment With Encorafenib + Binimetinib [Phase 4]

See pricing